Scribd Logo
Upload

Welcome to Scribd!

  • 699 views

    Interferon Drug Study

    Uploaded by

    jogzzz13
    1. Interferon beta-1a and beta-1b are immunomodulators indicated for treating relapsing forms of multiple sclerosis to slow disability progression and decrease relapse frequency. 2. Common adverse reactions include headache, flu-like symptoms, nausea, myalgia, upper respiratory tract infection, fever, pain, asthenia, chills, infection, and sleep difficulty. 3. Nursing considerations include monitoring for depression, hypersensitivity reactions, pregnancy status, and side effects through periodic hematologic and hepatic enzyme testing.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd

    Interferon Drug Study

    Uploaded by

    jogzzz13
    699 views3 pages
    1. Interferon beta-1a and beta-1b are immunomodulators indicated for treating relapsing forms of multiple sclerosis to slow disability progression and decrease relapse frequency. 2. Common adverse reactions include headache, flu-like symptoms, nausea, myalgia, upper respiratory tract infection, fever, pain, asthenia, chills, infection, and sleep difficulty. 3. Nursing considerations include monitoring for depression, hypersensitivity reactions, pregnancy status, and side effects through periodic hematologic and hepatic enzyme testing.

    Original Description:

    interferon

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    1. Interferon beta-1a and beta-1b are immunomodulators indicated for treating relapsing forms of multiple sclerosis to slow disability progression and decrease relapse frequency. 2. Common adverse reactions include headache, flu-like symptoms, nausea, myalgia, upper respiratory tract infection, fever, pain, asthenia, chills, infection, and sleep difficulty. 3. Nursing considerations include monitoring for depression, hypersensitivity reactions, pregnancy status, and side effects through periodic hematologic and hepatic enzyme testing.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    699 views3 pages

    Interferon Drug Study

    Uploaded by

    jogzzz13
    1. Interferon beta-1a and beta-1b are immunomodulators indicated for treating relapsing forms of multiple sclerosis to slow disability progression and decrease relapse frequency. 2. Common adverse reactions include headache, flu-like symptoms, nausea, myalgia, upper respiratory tract infection, fever, pain, asthenia, chills, infection, and sleep difficulty. 3. Nursing considerations include monitoring for depression, hypersensitivity reactions, pregnancy status, and side effects through periodic hematologic and hepatic enzyme testing.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 3

    Brand/Generic Classification Action Indication Adverse Nursing Consideration

    Name Reaction

    Interferon Interferon beta 1a is Interferon beta- Headache, 1. List age at


    beta-1a / produced by 1a: indicated for flu-like diagnosis, frequency
    Avonex Immunomodul
    mammalian cells the treatment of symptoms, of exacerbations,
    ator into which the patients with nausea, other therapies
    human interferon relapsing forms of myalgia, prescribed, outcome.
    Interferon beta gene has been multiple sclerosis URTI, fever,
    2. Note any
    beta-1b / introduced. to slow the pain,
    hypersensitivity to
    Betaseron Interferon beta-1b is accumulation of asthynia,
    human albumin or
    a genetically physical disability chills,
    interferon beta.
    engineered plasmid and decrease the infection,
    Assess psychological
    containing the gene frequency of sleep
    status noting
    for human clinical difficulty,
    depression or
    interferon betaser17. exacerbations. dizziness,
    suicidal ideations;
    Interferon betas Patients with diarrhea,
    use with extreme
    have antiviral, multiple sclerosis sinusitis
    caution.
    antiproliferative, in whom efficacy
    and has been 3. Determine if
    immunoregulatory demonstrated pregnant; drug has
    effects. Mechanism include patients abortifacient
    for the beneficial who have properties.
    effect in the MS is experienced a first
    unknown, although clinical episode 4. Monitor
    hematologic profile
    the effects are and have MRI and hepatic enzyme
    mediated through features levels q 3 months.
    combination with consistent with
    specific cell multiple sclerosis.
    receptors located on Safety and
    the cell membrane. efficacy in patients
    The receptor-drug with chronic
    complex induces progressive
    the expression of a multiple sclerosis
    number of have not been
    interferon – induced established.
    gene products that
    are thought to be
    the mediators of the Interferon beta-
    biologic effects of 1b: is indicated for
    interferon beta-1a the treatment of
    and beta-1b. relapsing forms of
    multiple sclerosis
    to reduce the
    frequency of
    clinical
    exacerbations.
    Patients with
    multiple sclerosis
    in whom efficacy
    has been
    demonstrated
    include patients
    who have
    experienced a first
    clinical episode
    and have MRI
    features
    consistent with
    multiple sclerosis.

    You might also like